Benitec Biopharma Inc. SEC filings BNTC
Benitec Biopharma Inc. has 334 filings in SEC EDGAR's recent list, going back to Apr 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 14, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Auditor change
|
Sep 30, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Auditor change
|
Sep 24, 2026 | Sep 18, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Officer or director change
|
May 29, 2026 | May 22, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Dec 2, 2025 | Dec 1, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 7, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Nov 3, 2025 | Nov 2, 2025 |
| 8-K |
Current report
Results of operations
|
Sep 22, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Restatement
|
Sep 12, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Other events
|
Mar 28, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 27, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 26, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Other events
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2025 | Feb 14, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 31, 2024 | Dec 27, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 10, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 6, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 14, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2024 | Oct 12, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 11, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Other events
|
Oct 8, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Results of operations
|
Sep 26, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 5, 2024 | Aug 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 19, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 18, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 7, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2023 | Nov 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Other events
|
Sep 28, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Results of operations
|
Sep 21, 2023 | Sep 21, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 18, 2023 | Sep 13, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 11, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 10, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jul 25, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 15, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Listing notice
|
Mar 8, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2023 | Jan 23, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 12, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Dec 8, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 18, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 16, 2022 | Sep 12, 2022 |
| 8-K |
Current report
Listing notice
|
Sep 7, 2022 | Sep 6, 2022 |
| 8-K |
Current report
Results of operations
|
Sep 2, 2022 | Sep 2, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2022 | Feb 14, 2022 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jan 21, 2022 | Dec 8, 2021 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 21, 2021 | Dec 17, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 13, 2021 | Dec 8, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2021 | Sep 15, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 20, 2021 | Sep 20, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 29, 2021 | Apr 27, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 24, 2021 | Feb 24, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2020 | Dec 9, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 14, 2020 | Dec 9, 2020 |
| 8-K |
Current report
Auditor change
|
Nov 3, 2020 | Nov 1, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 6, 2020 | Oct 2, 2020 |
| 8-K |
Current report
Results of operations
|
Sep 23, 2020 | Sep 23, 2020 |
| 8-K/A |
Amended current report
Auditor change
|
Aug 19, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Other events
|
Aug 18, 2020 | Aug 14, 2020 |
| 8-K |
Current report
Auditor change
|
Jun 5, 2020 | Jun 5, 2020 |
Showing 82 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BNTC (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Hayward, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1808898
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.